The University of Minnesota Medical Scientist Training Program (MD/PhD) recruits a diverse group of gifted scholars with the highest caliber intellectual skills and character traits to pursue a rigorous, supportive physician scientist training sequence that results in the awarding of both an MD and PhD in 8 years or less. The pillars of our training program are an integration of clinical medicine and scientific discovery through all phases of training, flexibility to meet the specific needs of individual students, continuous mentoring and career development, community building to promote student retention, success, and well-being, and an enduring commitment to diversity and inclusion as a foundation for excellence. Outstanding faculty preceptors provide research opportunities in the biomedical sciences, engineering, computational biology, medicinal chemistry, chemistry, epidemiology, and a new PhD opportunity in health policy. Significant investments in infrastructure and physician scientist training across the career continuum have enhanced program development and success. Our leadership team, which includes a new third Associate Director position, has clearly defined responsibilities, and three new Associate Directors with complementary skills and expertise have been appointed. Continuous quality improvement driven by feedback from our evaluation plan has resulted in refinement of our longitudinal clinical continuity program during the PhD phase, increased numbers of women and URM faculty preceptors, an expanded Women in Science and Medicine seminar program, new formal exposure of first and second year MSTP students to grant writing and other professional competencies critical for success in the PhD phase, new Research Showcase meetings to introduce new students to research opportunities, a new PhD phase MSTP orientation session, a revised IDP, a new annual progress meeting where the program meets with both the student and PhD advisor, and new resources and initiatives to help advisors continue to improve their mentoring skills. A revised student governance structure has provided more opportunities for students to develop leadership skills, lead program activities, enhance engagement with our alumni, and improve program cohesion across years. During the past funding cycle, our trainees have published in top-tier journals, and 24 trainees have been supported by NIH F30 or F31 awards. Our trainees have successfully matched in outstanding residency and PSTP programs, and are successfully moving into academic faculty positions. Our applicant pool is national in scope and total numbers are the highest ever, with a 59% increase in applications compared to 2014. We have successfully recruited an average of 9 students per year over the last 5 years while increasing our admissions yield. Our current student cohort is diverse, with 48% women and 22% from under-represented groups. A student-led diversity and inclusion group fosters an outstanding program climate and student well-being. Increased support is being requested so that we can build on this track record of success in matriculating, retaining and graduating top-tier MSTP students.

Public Health Relevance

The University of Minnesota Medical Scientist Training Program (MD/PhD) provides a rigorous, supportive program of study for an outstanding and diverse group of students who will become leading physician scientists. By combining medical training with research training that will lead to new scientific discoveries, this integrated training program will help meet the nation?s critical need for investigators who can successfully translate scientific discoveries into new preventive strategies and therapies that will improve the lives of patients.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM008244-33
Application #
9852690
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Maas, Stefan
Project Start
1988-07-01
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
33
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pathology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Verma, Mayank; Asakura, Yoko; Murakonda, Bhavani Sai Rohit et al. (2018) Muscle Satellite Cell Cross-Talk with a Vascular Niche Maintains Quiescence via VEGF and Notch Signaling. Cell Stem Cell 23:530-543.e9
Sweis, Brian M; Abram, Samantha V; Schmidt, Brandy J et al. (2018) Sensitivity to ""sunk costs"" in mice, rats, and humans. Science 361:178-181
Csizmar, Clifford M; Petersburg, Jacob R; Hendricks, Alex et al. (2018) Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors. Bioconjug Chem 29:1291-1301
Breed, Elise R; Lee, S Thera; Hogquist, Kristin A (2018) Directing T cell fate: How thymic antigen presenting cells coordinate thymocyte selection. Semin Cell Dev Biol 84:2-10
Sweis, Brian M; Larson, Erin B; Redish, A David et al. (2018) Altering gain of the infralimbic-to-accumbens shell circuit alters economically dissociable decision-making algorithms. Proc Natl Acad Sci U S A 115:E6347-E6355
Meier, Lee A; Auger, Jennifer L; Engelson, Brianna J et al. (2018) CD301b/MGL2+ Mononuclear Phagocytes Orchestrate Autoimmune Cardiac Valve Inflammation and Fibrosis. Circulation 137:2478-2493
Sweis, Brian M; Redish, A David; Thomas, Mark J (2018) Prolonged abstinence from cocaine or morphine disrupts separable valuations during decision conflict. Nat Commun 9:2521
Angelos, Mathew G; Abrahante, Juan E; Blum, Robert H et al. (2018) Single Cell Resolution of Human Hematoendothelial Cells Defines Transcriptional Signatures of Hemogenic Endothelium. Stem Cells 36:206-217
Ebrahimi, Diako; Richards, Christopher M; Carpenter, Michael A et al. (2018) Genetic and mechanistic basis for APOBEC3H alternative splicing, retrovirus restriction, and counteraction by HIV-1 protease. Nat Commun 9:4137
Titcombe, Philip J; Wigerblad, Gustaf; Sippl, Natalie et al. (2018) Pathogenic Citrulline-Multispecific B Cell Receptor Clades in Rheumatoid Arthritis. Arthritis Rheumatol 70:1933-1945

Showing the most recent 10 out of 108 publications